Cafe Scientifique - An overview of drug discovery and drug design
20th February 2018
Drug discovery is the process by which new medicines are identified to treat specific diseases or indications that have an unmet clinical need. In order to provide a safe and effective treatment for patients a significant financial and time investment is required, with the typical development time being 10-15 years. Drug discovery and development involves a wide range of different scientific disciplines including biology, chemistry and pharmacology. This talk will describe the challenges involved in designing new drugs and explain the different stages that make up the drug discovery process from target identification through to candidate selection for clinical trials.
Heather Twin completed her undergraduate masters degree in Chemistry at the University of Manchester (UMIST) in 1998. She then went on to obtain a PhD in synthetic organic chemistry at the University of Exeter followed by post-doctoral studies at the University of Toronto, Canada. She returned to the UK to commence her career as a medicinal chemist at the Oxford site of Vertex Pharmaceuticals, a global biotech company. She has worked on a range of drug discovery programs focused predominantly on oncology and immunology targets. Her current role is as a Research Fellow involved with early stage programs for a range of diseases with a clear unmet medical need